The use of mycophenolate mofetil in experimental encapsulating peritoneal sclerosis.

about

Abatacept as a therapeutic option in the treatment of encapsulated peritoneal sclerosis: an experimental rat model.

P2860

Q52908558-2FC8AA59-AF75-4A39-9754-6521C250A6B1

P2860

The use of mycophenolate mofetil in experimental encapsulating peritoneal sclerosis.

Item

http://www.wikidata.org/entity/Q53433459

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh-hant

name

The use of mycophenolate mofetil in experimental encapsulating peritoneal sclerosis.

@en

The use of mycophenolate mofetil in experimental encapsulating peritoneal sclerosis.

@nl

type

Item

label

The use of mycophenolate mofetil in experimental encapsulating peritoneal sclerosis.

@en

The use of mycophenolate mofetil in experimental encapsulating peritoneal sclerosis.

@nl

prefLabel

The use of mycophenolate mofetil in experimental encapsulating peritoneal sclerosis.

@en

The use of mycophenolate mofetil in experimental encapsulating peritoneal sclerosis.

@nl

P1476

The use of mycophenolate mofetil in experimental encapsulating peritoneal sclerosis.

@en

P2093

Alper Azak

http://www.w3.org/2001/XMLSchema#string

Bülent Huddam

http://www.w3.org/2001/XMLSchema#string

Funda Yalçın

http://www.w3.org/2001/XMLSchema#string

Gülay Koçak

http://www.w3.org/2001/XMLSchema#string

Murat Başaran

http://www.w3.org/2001/XMLSchema#string

Murat Duranay

http://www.w3.org/2001/XMLSchema#string

Nihan Haberal Reyhan

http://www.w3.org/2001/XMLSchema#string

P2860

The accumulated experience with the use of mycophenolate mofetil in primary glomerulonephritis.

Can effluent matrix metalloproteinase 2 and plasminogen activator inhibitor 1 be used as biomarkers of peritoneal membrane alterations in peritoneal dialysis patients?

Treating skin and lung fibrosis in systemic sclerosis: a future filled with promise?

Interstitial lung disease in rheumatoid arthritis.

An experimental sclerosing encapsulating peritonitis model in mice.

Activation of matrix metalloproteinase-2 causes peritoneal injury during peritoneal dialysis in rats.

Mycophenolate mofetil inhibits intimal hyperplasia and attenuates the expression of genes favouring smooth muscle cell proliferation and migration.

A case of encapsulating peritoneal sclerosis at the clinical early stage with high concentration of matrix metalloproteinase-2 in peritoneal effluent.

Successful treatment of encapsulating peritoneal sclerosis with immunosuppressive therapy.

The potential of matrix metalloproteinase-2 as a marker of peritoneal injury, increased solute transport, or progression to encapsulating peritoneal sclerosis during peritoneal dialysis--a multicentre study in Japan.

P304

1423-1428

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11255-015-1015-Z

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-07-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

279989158

http://www.w3.org/2001/XMLSchema#string

P698

26159779

http://www.w3.org/2001/XMLSchema#string

The use of mycophenolate mofetil in experimental encapsulating peritoneal sclerosis.

about

P2860

P2860

The use of mycophenolate mofetil in experimental encapsulating peritoneal sclerosis.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698